This study compared the pre‐emptive and the prophylactic strategies used to prevent
cytomegalovirus (CMV) infection and disease in CMV‐seropositive orthotopic liver …

Background Cytomegalovirus (CMV) remains the leading viral cause of disease following
orthotopic liver transplantation (OLT) despite the availability of antiviral agents for …

Optimal measures for the prevention of cytomegalovirus (CMV) in high‐risk orthotopic liver
transplant (OLT) patients are unknown. The charts of high‐risk OLT recipients with 12 …

Context Cytomegalovirus (CMV) is an opportunistic infection that causes profound morbidity
and mortality after orthotopic liver transplant (OLT). The CMV immunoglobulin G …

Cytomegalovirus (CMV)-seronegative liver transplant recipients with CMV-seropositive
donors have the greatest risk for CMV disease. We performed a randomized, controlled trial …

The predictive factors for cytomegalovirus (CMV) infection in de novo liver transplant
patients were determined at 3 months posttransplantation. We included all consecutive …

Background Few studies have directly compared preemptive therapy (PET) and antiviral
prophylaxis (AP) for prevention of cytomegalovirus (CMV) disease in CMV seropositive (R+) …

Background Cytomegalovirus (CMV) can cause severe infections in transplanted patients.
To prevent CMV infection, most liver centers use prophylaxis for CMV-seronegative …

THE ORIGINAL PROPHYLACTIC studies of cyto-megalovirus immune globulin for the
prevention of cytomegalovirus (CMV) disease in orthotopic liver transplantation failed to …

BACKGROUND: Cytomegalovirus (CMV) is a significant infectious agent after liver
transplantation. To prevent CMV, most centres use prophylaxis for high-risk CMV …